000 | 01946 a2200553 4500 | ||
---|---|---|---|
005 | 20250515215713.0 | ||
264 | 0 | _c20110315 | |
008 | 201103s 0 0 eng d | ||
022 | _a1540-0514 | ||
024 | 7 |
_a10.1097/SHK.0b013e3181defaa1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCoelho, Ana Maria Mendonça | |
245 | 0 | 0 |
_aMechanisms of the beneficial effect of hypertonic saline solution in acute pancreatitis. _h[electronic resource] |
260 |
_bShock (Augusta, Ga.) _cNov 2010 |
||
300 |
_a502-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAmylases _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAscites _xmetabolism |
650 | 0 | 4 |
_aCyclooxygenase 2 _xanalysis |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aInterleukin-10 _xanalysis |
650 | 0 | 4 |
_aInterleukin-6 _xanalysis |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeutrophils _xenzymology |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xanalysis |
650 | 0 | 4 |
_aOligopeptides _xanalysis |
650 | 0 | 4 |
_aPancreatitis _xchemically induced |
650 | 0 | 4 |
_aPeroxidase _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSaline Solution, Hypertonic _xpharmacology |
650 | 0 | 4 |
_aTaurocholic Acid _xtoxicity |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
700 | 1 | _aJukemura, José | |
700 | 1 | _aSampietre, Sandra N | |
700 | 1 | _aMartins, Joilson O | |
700 | 1 | _aMolan, Nilza A T | |
700 | 1 | _aPatzina, Rosely A | |
700 | 1 | _aLindkvist, Björn | |
700 | 1 | _aJancar, Sonia | |
700 | 1 | _aCunha, José Eduardo M | |
700 | 1 | _aD'Albuquerque, Luiz A Carneiro | |
700 | 1 | _aMachado, Marcel Cerqueira Cesar | |
773 | 0 |
_tShock (Augusta, Ga.) _gvol. 34 _gno. 5 _gp. 502-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/SHK.0b013e3181defaa1 _zAvailable from publisher's website |
999 |
_c19712411 _d19712411 |